TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
Clinical trial NCT02927964 · COMPLETED
Trial details
- NCT number
- NCT02927964
- Sponsor
- Robert Lowsky
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-07
- Primary completion
- 2023-05-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.